close
Edit Metric
Company
Value
Source
Source URL
Notes
Cancel
 
close
Edit  |  History
Details
Company:
Value :
Source:
Source URL:
Notes:
 
Feedback  |  FAQ
Get involved

Merck (MRK)

Stock (Drug Manufacturers Industry, Drug Manufacturers - Major Industry, Pharma & Healthcare Industry)

Add a New Bears Reason
Company: Merck (MRK)
Current price:
Headline: (100 character max)
Analysis:
Cancel
0%
agree
0 votes

edit Drug development is costly and its success is inherently risky

Top Contributor: Kryssia Uraguchi | Created when MRK was $50.23 | Edit | History

Drug development is costly and its success is inherently uncertain. A candidate drug failing a late clinical trail would have significant financial consequences for the company.

(100 character max) Cancel
0%
agree
0 votes

edit The aftermath of Vioxx looks bleak

Top Contributor: Kryssia Uraguchi | Created when MRK was $50.23 | Edit | History

As the Vioxx lawsuit continues to be played out, negative headlines and cash outflows will be a long-term concern for the company. Litigation is an ongoing concern for pharmaceutical giants.

(100 character max) Cancel
0%
agree
0 votes

edit Patent expirations and generic competition is bad for revenues

Top Contributor: Kryssia Uraguchi | Created when MRK was $50.23 | Edit | History

30% of sales through 2008 may be affected by generics due to patent expirations.

(100 character max) Cancel
The Shelf
Contributions
Help make Wikinvest better! Learn how to get involved. And create an account to build your reputation.
Did you know…?
Bookmarks
Worried about pump and dump?
We review changes
for stock spam
» read more
Want to make Wikinvest better?
We need your help,
contribute today
» learn how
Do you write software?
We are recruiting
the best engineers
» view jobs
Like Wikinvest?
Spread the word —
Tell your friends!
» spread the word
Wikinvest © 2006, 2007, 2008. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki